[Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis]

Arch Bronconeumol. 2007 Jan;43(1):49-51.
[Article in Spanish]


Allergic bronchopulmonary aspergillosis is a lung disease characterized by an immune response to several antigens of Aspergillus species. Corticosteroids are the treatment of choice in the acute phase, although some studies have shown the efficacy of itraconazole. We describe the case of a favorable, prolonged therapeutic response to voriconazole in a patient with allergic bronchopulmonary aspergillosis who did not tolerate itraconazole.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Antifungal Agents / adverse effects
  • Antifungal Agents / therapeutic use*
  • Aspergillosis, Allergic Bronchopulmonary / drug therapy*
  • Female
  • Humans
  • Itraconazole / adverse effects
  • Itraconazole / therapeutic use
  • Middle Aged
  • Pyrimidines / therapeutic use*
  • Triazoles / therapeutic use*
  • Voriconazole


  • Adrenal Cortex Hormones
  • Antifungal Agents
  • Pyrimidines
  • Triazoles
  • Itraconazole
  • Voriconazole